Vismodegib in Locally Advanced Basal Cell Carcinoma in Slovenia
Conclusion: Vismodegib has shown meaningful efficacy with DCR from 95% to 100% in patients with laBCC, multiple BCC, and G-G Syn in Slovenia. TEAEs were successfully alleviated with multidisciplinary approach and early supportive care.Dermatology
Source: Dermatology - Category: Dermatology Source Type: research
More News: Basal Cell Carcinoma | Cancer & Oncology | Carcinoma | Dermatology | Gorlin syndrome | Skin | Skin Cancer | Slovenia Health | Study